{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antibiotics",
      "Enterolactone",
      "Epidemiology",
      "Lignans",
      "Microbiota"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "27500753",
  "DateCompleted": {
    "Year": "2017",
    "Month": "12",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "09",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/mnfr.201600566"
    ],
    "Journal": {
      "ISSN": "1613-4133",
      "JournalIssue": {
        "Volume": "60",
        "Issue": "12",
        "PubDate": {
          "Year": "2016",
          "Month": "Dec"
        }
      },
      "Title": "Molecular nutrition & food research",
      "ISOAbbreviation": "Mol Nutr Food Res"
    },
    "ArticleTitle": "Use of antibiotics is associated with lower enterolactone plasma concentration.",
    "Pagination": {
      "StartPage": "2712",
      "EndPage": "2721",
      "MedlinePgn": "2712-2721"
    },
    "Abstract": {
      "AbstractText": [
        "High enterolactone levels may have health benefits in relation to risk of noncommunicable diseases. Enterolactone is produced by the colonic microbiota after intake of lignans and treatment with antimicrobials may result in altered enterolactone production. This study investigates the association between antibiotic use and enterolactone concentration.",
        "Using LC-MS/MS, enterolactone concentrations were quantified in plasma samples from 2237 participants from the Diet, Cancer and Health cohort. The participants were healthy at enrollment, but were later diagnosed with cancer. At enrollment, participants had blood drawn and completed a food frequency questionnaire and lifestyle questionnaire. Antibiotic use was assessed as reimbursed antibiotic prescriptions up to 12 months before enrollment. Antibiotic use \u22643 months before enrollment was associated with a 41% (\u0394<sub>crude</sub> : -41; 95% CI: -52, -28) lower enterolactone concentration in women and 12% in men (\u0394<sub>crude</sub> : -12; 95% CI: -31, 11), while antibiotic use >3-12 months before enrollment was associated with 26% lower enterolactone in women (\u0394<sub>crude</sub> : -26; 95% CI: -37, -14) and 14% in men (\u0394<sub>crude</sub> : -14; 95% CI: -28, 1).",
        "Use of antibiotics up to 12 months before enrollment was associated with lower plasma enterolactone levels, especially among women."
      ],
      "CopyrightInformation": "\u00a9 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Animal Science, Aarhus University, Tjele, Denmark."
          }
        ],
        "LastName": "Bolvig",
        "ForeName": "Anne K",
        "Initials": "AK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark."
          }
        ],
        "LastName": "Kyr\u00f8",
        "ForeName": "Cecilie",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Animal Science, Aarhus University, Tjele, Denmark."
          }
        ],
        "LastName": "N\u00f8rskov",
        "ForeName": "Natalja P",
        "Initials": "NP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark."
          }
        ],
        "LastName": "Eriksen",
        "ForeName": "Anne K",
        "Initials": "AK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark."
          }
        ],
        "LastName": "Christensen",
        "ForeName": "Jane",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark."
          }
        ],
        "LastName": "Tj\u00f8nneland",
        "ForeName": "Anne",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Animal Science, Aarhus University, Tjele, Denmark."
          }
        ],
        "LastName": "Knudsen",
        "ForeName": "Knud E Bach",
        "Initials": "KE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark."
          }
        ],
        "LastName": "Olsen",
        "ForeName": "Anja",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Mol Nutr Food Res",
    "NlmUniqueID": "101231818",
    "ISSNLinking": "1613-4125"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lignans"
    },
    {
      "RegistryNumber": "OL659KIY4X",
      "NameOfSubstance": "4-Butyrolactone"
    },
    {
      "RegistryNumber": "X01E7E1D6H",
      "NameOfSubstance": "2,3-bis(3'-hydroxybenzyl)butyrolactone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analogs & derivatives",
        "blood"
      ],
      "DescriptorName": "4-Butyrolactone"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "adverse effects"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Mass Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cohort Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Gastrointestinal Microbiome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Life Style"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "blood"
      ],
      "DescriptorName": "Lignans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Linear Models"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nutrition Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Surveys and Questionnaires"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tandem Mass Spectrometry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}